![ACS Journal Cancer Editor-in-Chief, Suresh S. Ramalingam, is sharing the primary results of the phase 3 LAURA trial at ASCO](https://oncodaily.com/pub/uploads/2024/05/GORUZifXMAEfx8u-1280x720.jpeg)
Photo taken from ACS Journal Cancer/X
May 24, 2024, 14:15
ACS Journal Cancer Editor-in-Chief, Suresh S. Ramalingam, is sharing the primary results of the phase 3 LAURA trial at ASCO
ACS Journal Cancer shared the following on X:
“Our Editor-in-Chief, Suresh S. Ramalingam, is sharing the primary results of the phase 3 LAURA trial at this year’s ASCO Plenary Session! ICYMI: Dr. Ramalingam and Ticiana Batista recently authored an editorial on the 20th anniversary of EGFR.”
Source: ACS Journal Cancer/X
>
Jul 26, 2024, 00:27